James R Murphy's Net Worth

$7.46 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is James R Murphy?

James R Murphy has an estimated net worth of $7.46 Million. This is based on reported shares across multiple companies, which include CPEX Pharmaceuticals, Inc., and BENTLEY PHARMACEUTICALS INC.

SEC CIK

James R Murphy's CIK is 0001218893

Past Insider Trading and Trends

2008 was James R Murphy's most active year for acquiring shares with 13 total transactions. James R Murphy's most active month to acquire stocks was the month of September. 2008 was James R Murphy's most active year for disposing of shares, totalling 33 transactions. James R Murphy's most active month to dispose stocks was the month of June. 2006 saw James R Murphy paying a total of $946,000.00 for 364,000 shares, this is the most they've acquired in one year. In 2008 James R Murphy cashed out on 1,377,220 shares for a total of $6,921,179.38, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CPEX Pharmaceuticals, Inc. No price found

Investor

James R Murphy owns 115,957 units of Common Stock, $0.01 par value. James R Murphy used to own units in Common Stock and Restricted Stock Unit but no longer holds any shares there.acquired a total of 73,067 shares in CPEX Pharmaceuticals, Inc. at a cost of $566,338.08, James also disposed a total of 124,168 shares of CPEX Pharmaceuticals, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-124.17K
—
—
0
Apr 5
Form 4
—
0
—
—
0
Jun 18
Form 4
+154.35%
70.37K
$8.05
$566,338.09
115.96K
Oct 10
Form 4
+6.30%
2.7K
—
—
45.59K
Jul 22
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

BENTLEY PHARMACEUTICALS INC No price found

Chairman and CEO

James R Murphy owns 413,228 units of Common Stock, $.02 par value. James R Murphy used to own units in Common Stock, $0.02 par value but no longer holds any shares there.acquired a total of 647,000 shares in BENTLEY PHARMACEUTICALS INC at a cost of $2,389,290.00, James also disposed a total of 768,987 shares of BENTLEY PHARMACEUTICALS INC equalling to $10,414,802.61.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-441.11K
$14.82
-$6,535,765.58
0
Jul 22
Form 4
+2.69%
11.25K
—
—
428.9K
May 23
Form 4
+1.07%
4.42K
$11.97
-$27,818.62
417.65K
May 23
Form 4
—
0
—
—
0
May 23
Form 4
+24.31%
80.8K
$8.86
-$601,773.04
413.23K
Mar 23
Form 4
+35.56%
87.21K
$7.71
-$586,486.20
332.43K
Sep 30
Form 4
+94.64%
119.23K
$6.99
-$490,133.45
245.22K
Jun 2
Form 4
—
0
—
—
0
Mar 30
Form 4
+1.61%
2K
$11.25
$22,500.00
125.99K
Jun 7 - Jun 9
Form 4
+0.08%
100
$12.20
$1,220.00
123.99K
May 12
Form 4
+0.32%
400
$10.80
$4,320.00
123.89K
Mar 2
Form 4
—
0
—
—
0
Jan 1
Form 4
+40.00%
200
$15.45
$3,090.00
700
Oct 6
Form 4
+1.23%
1.5K
$5.00
$7,500.00
123.49K
Aug 7
Form 4
—
0
—
—
0
No matching records found